Back to Alzheimers Disease
NCT01734395
NCT01734395
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with Alzheimer's disease based on recognised medical guidelines
- Your score on a standard memory and thinking test (called the K-MMSE) is between 10 and 24, indicating mild to moderate difficulties
- You have a trusted family member, carer, or guardian who can reliably support you during the trial
Who may not be able to join:
- You have been diagnosed with a brain tumour, syphilis affecting the brain, meningitis, encephalitis, or epilepsy
- You have a significant mental health condition such as severe depression or schizophrenia
- You have stomach or peptic ulcers that have not responded to treatment
- You have a serious ongoing condition affecting the liver, kidneys, lungs, or hormone-producing glands, such as thyroid problems, parathyroid problems, pituitary problems, kidney failure, or diabetes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Janssen Korea, Ltd., Korea
Registry
clinicaltrials_gov
Start date
1 March 2007
Est. completion
1 January 2008
Primary endpoints
Change From Baseline at Week 16 in Attention Questionnaire Scores (AQS); Change From Baseline at Week 16 in Burden Interview (BI) Scores
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.